Reducing Nitrous Oxide Emissions Across the Melbourne Biomedical Precinct.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 42402525.
- Also identified by DOI 10.5694/mja2.70243.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nitrous oxide (N<sub>2</sub>O) accounts for the majority of Australian healthcare's direct anaesthetic gas-related greenhouse gas emissions due to reticulated system leaks. Updated Australasian guidelines no longer mandate a reticulated N<sub>2</sub>O supply. We present the efforts of four Melbourne hospitals to reduce N<sub>2</sub>O emissions across diverse clinical contexts. Two have decommissioned reticulated N<sub>2</sub>O and adopted cylinder supplies as required through clinical consultation and interdisciplinary collaboration. Two face ongoing high clinical demand for N<sub>2</sub>O, with multiple locations sharing infrastructure, and are pursuing audits and trials to guide change. These case studies illustrate the diverse strategies and challenges involved in reducing N<sub>2</sub>O emissions.
Medical subject headings
- Nitrous Oxide
- Anesthetics, Inhalation